Effect of vaginally administered 15(S)15-methyl-PGF2alpha on egg transport and fertility in rabbits.
The effects of vaginal suppositories containing 1.0 mg of 15[S]15-methy-PGF2alpha on oviductal motility, egg transport, and fertility were determined in rabbits. Suppository treatment caused a significant increase (P less than 0.02) in the amplitude of oviductal contractions, and a decrease in the frequency of contractractions (P less than 0.04). Altered oviductal motility persisted for an average of 2 hr after treatment. Treatment with 1, 2, or 3 suppositories at various times after ovulation caused a significant reduction in the number of eggs located in the oviducts (P less than 0.025). There was, however, a great deal of variation in egg recovery in treated animals (range 0 to 100%). Treatment of mated rabbits during the time of tubal egg transport caused a significant reduction in the number of Day-12 implants (P less than 0.05). The percentage of corpora lutea represented by Day-12 implants was similar to egg recovery rates in animals similarly treated. The treatment had no effect on fetal survival from Day 12 to 28 of pregnancy. The decrease in fertility caused by these vaginal suppositories is presumably due to the stimulatory effect on oviductal motility which accelerates tubal transport of the embryos into the uterus. Embryos that arrive in the uterus prematurely probably do not implant and degenerate or are expelled.
D000818:Animals; D005260:Female; D005298:Fertility / Q000187:drug effects*; D009119:Muscle Contraction / Q000187:drug effects; D010066:Ovum Transport / Q000187:drug effects*; D011460:Prostaglandins F / Q000008:administration & dosage / Q000494:pharmacology*; D011817:Rabbits; D013488:Suppositories
D011460:Prostaglandins F; D013488:Suppositories